Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 55 Carboplatin 55 Pemetrexed 47 Cisplatin 37 Paclitaxel 21 Nivolumab 20 Docetaxel 19 durvalumab 18 osimertinib 14 Gemcitabine 14 Cetuximab 14 130-nm albumin-bound paclitaxel 14 atezolizumab 12 Specimen Handling 12 Magnetic Resonance Spectroscopy 12 amivantamab 10 Radiotherapy 8 lazertinib 7 Taxes 7 Radiosurgery 7 alectinib 6 Ramucirumab 6 Observation 6 Ipilimumab 6 Bevacizumab 6 cemiplimab 5 Leucovorin 5 Fluorouracil 5 zimberelimab 4 entrectinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Non-Small-Cell Lung × NPI 2358 × 30 days × Clear all

NCT02504489 2026-05-19

DUBLIN-3

BeyondSpring Pharmaceuticals Inc.

Phase 3 Completed

559 enrolled 32 charts

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡